Mélanie Daligault

Treatment of antibody‐mediated rejection with double‐filtration plasmapheresis, low dose IVIg plus rituximab after kidney transplantation

L. Rostaing, Johan Noble, B. Janbon, 2021, Journal of clinical apheresis.

Immune responses following tocilizumab therapy to desensitize HLA‐sensitized kidney transplant candidates

L. Rostaing, Johan Noble, P. Saas, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates

L. Rostaing, Johan Noble, P. Malvezzi, 2021, Transplantation direct.

Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation

L. Rostaing, Johan Noble, B. Janbon, 2021, Journal of clinical medicine.

Immortal Time-Bias–Corrected Survival of Highly Sensitized Patients and HLA-desensitized Kidney Transplant Recipients

L. Rostaing, Johan Noble, B. Janbon, 2021, Kidney international reports.

Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to Apheresis: The TETRA Study

L. Rostaing, Johan Noble, P. Malvezzi, 2023, Journal of clinical medicine.